Browse by People

Collapse authors list.
Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Fowotade, Adeola, Olagunoye, Ajibola, Ojo, Temitope Olumuyiwa, Adefuye, Bolanle Olufunlola, Fagbamigbe, Adeniyi Francis, Adebiyi, Akindele Olupelumi, Olagunju, Omobolanle Ibitayo, Ladipo, Olabode Taiwo, Akinloye, Abdulafeez et al (show 6 more authors) , Adeagbo, Babatunde Ayodeji, Onayade, Adedeji, Bolaji, Oluseye Oladotun, Happi, Christian, Rannard, Steve ORCID: 0000-0002-6946-1097 and Owen, Andrew ORCID: 0000-0002-9819-7651 (2021) Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial. Trials, 22 (1). 3-.

Collapse authors list.
Fowotade, Adeola, Bamidele, Folasade, Egbetola, Boluwatife, Fagbamigbe, Adeniyi F, Adeagbo, Babatunde A, Adefuye, Bolanle O, Olagunoye, Ajibola, Ojo, Temitope O, Adebiyi, Akindele O, Olagunju, Omobolanle I et al (show 8 more authors) , Ladipo, Olabode T, Akinloye, Abdulafeez, Onayade, Adedeji, Bolaji, Oluseye O, Rannard, Steve ORCID: 0000-0002-6946-1097, Happi, Christian, Owen, Andrew ORCID: 0000-0002-9819-7651 and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749 (2022) A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19. FRONTIERS IN MEDICINE, 9. 956123-.